Novartis Investigative Site

Suresnes, France 92150

0 studies enrolling now · 2 studies all time

What they study most

Adenocarcinoma, Carcinoma, Hypernephroid, Metastatic Renal Cell Carcinoma, Nephroid Carcinoma, Renal Cell

Studies at this site

• Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab for the First-line Treatment in Adult Patients With Kidney Cancer — Completed
• Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma — Completed